Dicerna Pharmaceuticals Inc Business Operations Contracts & Agreements
12 Contracts & Agreements
- Collaboration Agreements (7 contracts)
- Development Agreements (1)
- Indemnification Agreements (2)
- Sales Agreements (1)
- Settlement Agreements (1)
- Sales Agreement, dated as of May 6, 2021, between the Registrant and Cowen and Company, LLC (Filed With SEC on May 6, 2021)
- Second Amendment to Collaboration and License Agreement, by and between the Company and F. Hoffman-La Roche Inc., dated as of June 22, 2020 (Filed With SEC on August 6, 2020)
- First Amendment to Collaboration and License Agreement by and between the Company and F. Hoffman-La Roche Inc., dated as of May 22, 2020 (Filed With SEC on August 6, 2020)
- Collaboration and License Agreement by and between the Company and Alnylam Pharmaceuticals, Inc., dated as of April 3, 2020 (Filed With SEC on August 6, 2020)
- Collaboration and License Agreement, dated October 25, 2018, by and between the Company and Eli Lilly and Company (Filed With SEC on March 13, 2019)
- Confidential Settlement Agreement and General Release, dated as of April 18, 2018, between the Company and Alnylam Pharmaceuticals, Inc (Filed With SEC on August 8, 2018)
- RESEARCH COLLABORATION AND LICENSE AGREEMENT BETWEEN DICERNA PHARMACEUTICALS,INC. AND KYOWA HAKKO KIRINCO., LTD. December 21, 2009 (Filed With SEC on January 29, 2014)
- RESEARCH COLLABORATION AND LICENSE AGREEMENT BETWEEN DICERNA PHARMACEUTICALS,INC. AND KYOWA HAKKO KIRINCO., LTD. December 21, 2009 (Filed With SEC on January 28, 2014)
- DICERNA PHARMACEUTICALS, INC. FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on January 28, 2014)
- RESEARCH COLLABORATION AND LICENSE AGREEMENT BETWEEN DICERNA PHARMACEUTICALS,INC. AND KYOWA HAKKO KIRINCO., LTD. December 21, 2009 (Filed With SEC on January 17, 2014)
- DICERNA PHARMACEUTICALS, INC. FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on January 17, 2014)
- DEVELOPMENT AND SUPPLY AGREEMENT By and Among PROTIVA BIOTHERAPEUTICS INC. And TEKMIRA PHARMACEUTICALS CORPORATION ON THE ONE HAND, And DICERNA PHARMACEUTICALS, INC. ON THE OTHER... (Filed With SEC on March 12, 2015)
